I'd like reporters to be more informed. ERs Are

I'd like reporters to be more informed.

ERs Are Swamped With Seriously Ill Patients, Although Many Don’t Have Covid
10/29/2021
https://khn.org/news/article/hospital-emergen...-patients/
"Doctors and nurses say the severity of illness ranges widely and includes abdominal pain, respiratory problems, blood clots, heart conditions and suicide attempts, among other conditions."

The thrust of the article is that healthcare professionals are working hard. I agree with this, but I think that the reporter all too simply fails to make a connection to Covid19. When they attribute the "swamped" ER's to delayed or postponed care, yet the symptoms mentioned actually accompany the various phases of Covid-19 which include the viral, cytokine storm, and long-haulers (PACS) phases of Covid-19, good reporters should dig deeper. IMO the majority of reporters have not been on top of their craft and just parrot memes they've seen elsewhere.

I don't doubt that there are better links, but the graphic at the bloomberg link below gives perspective, and the Cytodyn press release link from their first long-haulers trial shows relevance. I think the reporter, like many of their peers, does their readers a disservice by not recognizing the detail of all the phases of Covid-19. JMO.

I'll leave readers here to look up cytokine storm issues, but below are other relevant links.

Covid-19 long-haulers symptoms
https://www.bloomberg.com/graphics/2020-opini...c-illness/

Cytodyn long-haulers phase 2 results
https://www.cytodyn.com/newsroom/press-releas...results-of
"Chris Recknor, M.D., CytoDyn’s Chief Operating Officer and Head of Clinical Development, commented, “We are very pleased with the preliminary results from our long-haulers trial, which showed a greater improvement in the leronlimab patient group over placebo in 18 of 24 COVID-19 symptoms. Although the study was not designed to show statistically significant differences due to the small sample size of 56 patients, clinically meaningful improvements in leronlimab over placebo were observed for:
cough,
stuffy/runny nose,
shortness of breath,
tightness of chest,
feeling of fast heartbeat,
fatigue,
muscle aches/cramps,
muscle weakness,
joint pain/swelling,
chills/shivering,
feeling hot or feverish,
difficulty in concentration,
sleep disturbance/insomnia,
headache,
dizziness,
tingling/numbness,
sense of taste, and
sense of smell"

There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.